M.P.C. Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 06-12-2024
- Paid Up Capital ₹ 0.38 M
as on 06-12-2024
- Company Age 13 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 42.60 Cr
as on 06-12-2024
- Satisfied Charges ₹ 2.94 Cr
as on 06-12-2024
- Revenue 29.75%
(FY 2023)
- Profit -39.96%
(FY 2023)
- Ebitda 19.00%
(FY 2023)
- Net Worth 3.51%
(FY 2023)
- Total Assets 27.06%
(FY 2023)
About M.P.C. Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.38 M.
The company currently has active open charges totaling ₹42.60 Cr. The company has closed loans amounting to ₹2.94 Cr, as per Ministry of Corporate Affairs (MCA) records.
Rahul Abraham, Mamman Abraham, Pameela Mamman, and One other member serve as directors at the Company.
- CIN/LLPIN
U51102TN2011PTC078857
- Company No.
078857
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Jan 2011
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at M.P.C. Pharma?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rahul Abraham  | Director | 17-Jan-2011 | Current |
| Mamman Abraham | Director | 17-Jan-2011 | Current |
| Pameela Mamman | Director | 17-Jan-2011 | Current |
| Miriam Verghese | Director | 17-Mar-2022 | Current |
Financial Performance and Corporate Structure Insights of M.P.C. Pharma.
M.P.C. Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 29.75% increase. The company also saw a substantial fall in profitability, with a 39.96% decrease in profit. The company's net worth moved up by a moderate rise of 3.51%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of M.P.C. Pharma?
In 2023, M.P.C. Pharma had a promoter holding of 72.96% and a public holding of 27.04%. The company had 8 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Thodupuzha Drug House Private LimitedActive 6 years 8 monthsRahul Abraham, Mamman Abraham and 1 more are mutual person
Medigenmed Care Private LimitedActive 5 years 6 monthsRahul Abraham, Mamman Abraham and 1 more are mutual person
- Haeal Enterprises Private LimitedActive 4 years 10 days
Rahul Abraham and Miriam Verghese are mutual person
- Cure Genic Hygiene Private LimitedActive 3 years 6 months
Rahul Abraham and Miriam Verghese are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 03 Jan 2024 | ₹0.04 M | Open |
Others Creation Date: 03 Oct 2023 | ₹1.00 Cr | Open |
Others Creation Date: 01 Sep 2023 | ₹7.50 M | Open |
How Many Employees Work at M.P.C. Pharma?
M.P.C. Pharma has a workforce of 36 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of M.P.C. Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped M.P.C. Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
